Results 151 to 160 of about 6,570 (168)

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2022
Michael J Cork, Andreas Wollenberg, Mercedes E. Gonzalez   +2 more
exaly  

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Lancet, The, 2021
E Guttman-Yassky, Ka Papp, Andrew Blauvelt   +2 more
exaly  

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Lancet, The, 2020
Rd Sinclair, Andreas Wollenberg, Michael J Cork   +2 more
exaly  

Atopic dermatitis

Lancet, The, 2020
Sinead M Langan, Alan D Irvine, Stephan Weidinger   +2 more
exaly  

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

Nature Reviews Drug Discovery, 2021
Thomas Bieber
exaly  

An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study

Lancet, The, 2023
E Guttman-Yassky, Kenji Kabashima, Masutaka Furue   +2 more
exaly  

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Lancet, The, 2017
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham   +2 more
exaly  

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2016
Thomas Bieber, Andrew Blauvelt, Margitta Worm   +2 more
exaly  

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial

Lancet, The, 2020
Håvard Ove Skjerven, Eva Maria Rehbinder, Riyas Vettukattil   +2 more
exaly  

Atopic dermatitis

Nature Reviews Disease Primers, 2018
Stephan Weidinger, Maiken Cavling Arendrup, Thomas Bieber   +2 more
exaly